01.08.2011 • NewsH1 2011sales and profitsAir Liquide

Air Liquide Q2 Profit up 11%

Air Liquide reported first-half net profit, group share, of €750 million, up 11.1% from last year. Earnings per share were €2.65 for the period, 10.4% higher than a year ago.

Group revenue totaled €7.11 billion for the first six months of 2011, representing an increase of 9.2% from the previous year. Excluding impact of currency and natural gas, on a comparable basis, group revenue grew 8.3%.

Benoît Potier, Chairman and CEO of the Air Liquide Group, said, "Business was sustained in the first half of 2011 and profits are up strongly. They reflect the positive momentum in our markets as well as the Group's ability to achieve a solid operating performance in an environment that was affected by world events, notably in Japan and the Middle-East. Assuming normal economic conditions, Air Liquide is confident in its ability to continue to generate steady growth of net profit in 2011."

 

Interview

Innovation at the Intersection of AI
Digital Potential in Key Business Areas

Innovation at the Intersection of AI

Stefan Guertzgen spoke with John Banovetz, Chief Technology Officer at 3M, about the role of digital transformation in achieving the company's objectives.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.